Suppr超能文献

仅通过化疗,结核性胸腔积液就有显著消退。

Significant resolution of tuberculous pleural effusion on chemotherapy alone.

作者信息

Loh L C, Lim B K, Wan Yusuf S

机构信息

Department of Medicine, Penang Medical College, 4 Jalan Sepoy Lines, 10450 Penang, Malaysia.

出版信息

J R Coll Physicians Edinb. 2010 Jun;40(2):100-4. doi: 10.4997/JRCPE.2010.202.

Abstract

BACKGROUND

As a standard, significant pleural effusion, whether tuberculous (TB) or not, requires therapeutic thoracocentesis. We tested the hypothesis that standard anti-TB chemotherapy alone can resolve significant pleural effusion.

METHODS

20 eligible patients with TB pleural effusion of at least 30% of the hemithorax (10 with moderate-size and 10 with large-size effusion, respectively) were retrospectively reviewed for radiological resolution of their effusions at two, six and 12 months after commencement of standard six-month therapy.

RESULTS

The mean percentage resolutions in both groups were comparable (48% vs 46% at two months; 59% vs 85% at six months; 84% vs 95% at 12 months). The mean sizes of effusions were also comparable (18% vs 33% at two months; 14% vs 10% at six months; 6% vs 4% at 12 months). Cigarette smoking and Indian ethnicity were univariately associated with incomplete resolution of effusions.

CONCLUSION

Standard anti-TB chemotherapy alone appears to be sufficient to resolve significant TB pleural effusion. An avoidance of therapeutic thoracocentesis may reduce the risk of infection exposure or allow better channelling of resources in certain clinical settings.

摘要

背景

作为一项标准,无论是否为结核性,大量胸腔积液均需要进行治疗性胸腔穿刺术。我们检验了仅采用标准抗结核化疗即可消除大量胸腔积液这一假设。

方法

回顾性分析20例符合条件的结核性胸腔积液患者,其胸腔积液至少占半侧胸腔的30%(分别为10例中等量积液和10例大量积液),观察标准6个月治疗开始后2个月、6个月和12个月时胸腔积液的影像学消退情况。

结果

两组的平均消退百分比具有可比性(2个月时分别为48%和46%;6个月时分别为59%和85%;12个月时分别为84%和95%)。积液的平均大小也具有可比性(2个月时分别为18%和33%;6个月时分别为14%和10%;12个月时分别为6%和4%)。吸烟和印度族裔在单因素分析中与积液消退不完全相关。

结论

仅采用标准抗结核化疗似乎足以消除大量结核性胸腔积液。在某些临床情况下,避免进行治疗性胸腔穿刺术可能会降低感染暴露风险或使资源分配更合理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验